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Functionalized carbon nanotubes ( f-CNT) are emerging as a new family of nanovectors for the delivery of different types of therapeutic
molecules. The application of CNT in the field of carrier-mediated delivery has become possible after the recent discovery of their capacity to
penetrate into the cells. CNT can be loaded with active molecules by forming stable covalent bonds or supramolecular assemblies based on
noncovalent interactions. Once the cargos are carried into various cells, tissues and organs they are able to express their biological function. In this
review, we will describe the potential of f-CNT to deliver different types of therapeutic molecules.
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In the past decade, the rediscovery of carbon nanotubes has
opened new frontiers in the field of nanotechnology and
nanoscience [1]. The unique structural, mechanical and1758 (2006) 404 – 412
http://www
Fig. 1. TEM images of single- (left) and multi-walled (right) carbon nanotubes.
While SWNT are present as bundles of different diameter and length, due to
their strong aggregation tendency, MWNT can be instead observed as isolated
entities. The scale bars correspond to 1 Am and 250 nm, respectively.
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of materials science [2]. Soon after this new types of
nanostructures started to be used in interaction mainly with
proteins aiming to develop efficient biosensors [3–8]. The
combination of nanotubes with proteins and other natural
products including nucleic acids and polysaccharides paved the
way for the compatibility of such materials with biological
systems. However, dispersibility of CNT in aqueous media is a
fundamental prerequisite to study their biological properties.
CNT are practically insoluble in any type of solvent and only
the recent development of strategies for linking chemical
moieties on the tubes has facilitated their applicability.
The possibility to form complexes between CNT and
different types of polymers or to modify the CNT sidewalls
by organic functionalization drastically increased the char-
acteristics of solubility of CNT. Depending on the type of
strategy (covalent or noncovalent) and moiety attached to or
interacting with the tubes, solubility can be modulated in
different solvents. As a consequence, a wide range of
applications has been envisaged including the use of CNT
as substrates for neuronal growth [9–11], supports for
adhesion of liposaccharides to mimic cell membrane [12],
ion channel blockers [13] and delivery systems [14,15]. This
review will focus on the application of carbon nanotubes for
drug delivery. Initially, CNT characteristics and strategies for
solubilization will be described. Then, the application as new
carrier systems for drugs, peptides, proteins and nucleic acids
will be discussed.
2. Carbon nanotubes
2.1. Structure and characteristics
Carbon nanotubes were discovered in the late 1950s, but
they have been reconsidered and studied thoroughly only
during the last 15 years [16,17]. They represent, along with
fullerenes, the third allotropic crystalline form of carbon. CNT
are basically a rolled sheet of graphite terminated by two end
caps similar to a half C60. Two main types of nanotubes exist:
(i) the single-walled carbon nanotubes (SWNT) which are
composed by a rolled monolayered graphene sheet, and (ii) the
multi-walled carbon nanotubes (MWNT) which possess
several graphitic concentric layers. The distance between each
layer of a MWNT is about 0.34 nm. When a nanotube contains
only two layers, it is referenced as double-walled carbon
nanotube (DWNT). The diameter varies from 0.4 to 2 nm for
SWNT and from 1.4 to 100 nm for MWNT, while the length
can reach several micrometers for both types. The high
electron density created by their aromatic structure makes
them easily observable by transmission electron microscopy.
SWNT can be seen mainly in bundles because of the strong
van der Waals interactions, whereas MWNT are mainly
monodispersed (Fig. 1). CNT exhibit different electrical
properties: SWNT can be either semi-conducting or metallic
while MWNT are only semi-conducting [18].
There are several methods to produce CNT including arc
discharge, laser ablation and chemical vapor deposition [19]. Asubcategory of the latter is the HiPCO (High-Pressure CO
Conversion) process, widely used because it can be easily
scaled-up to industrial production affording long length,
controllable diameter and acceptable CNT purity [20]. How-
ever, a further purification is always needed before any further
use. As-prepared nanotubes typically contain up to 30% metal
catalyst (mainly iron and nickel particles) and some amorphous
carbon and nanoparticles residual of the production procedure.
2.2. Purification of carbon nanotubes
One of the most commonly used technique for the pu-
rification and eventual solubilization of CNT is the oxidation
using strong acid treatments which permit removal of a large
part of the metallic impurities. Nevertheless, this methodology
is not devoid of consequences for the tubes. Indeed, strong acid
conditions cut the tubes in shorter pieces and generate
carboxylic functions at the tips and around the sidewalls where
the curvatures of the tubes present a higher strain. To avoid
this, alternative methods have been explored including GPC,
chromatography, centrifugation, filtration or other chemical
derivatization techniques [21–26]. These purification techni-
ques increase also the nanotube solubility making them easier
to separate from the insoluble impurities.
2.3. Solubilization of carbon nanotubes
CNT are materials practically insoluble, or hardly dispersed,
in any kind of solvent. To integrate the nanotube technology
with the biological milieu, the solubility of the tubes especially
in aqueous solutions must be improved. Several ways of
dispersion and solubilization have been explored and can be
basically divided in two main approaches. One procedure
consists on the noncovalent functionalization of CNT with
surfactants, nucleic acids, peptides, polymers and oligomers
[6,8,27–33]. The advantage of this process is the preservation
of the electronic structure of the nanotube aromatic surface.
This property is of fundamental importance for the use of
nanotubes as biosensors. The second methodology is based on
CNT covalent functionalization [34–38]. First, CNT are cut
and oxidized to generate a certain number of carboxylic groups
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Alternatively, CNT sidewalls can be directly functionalized by
addition reactions. The introduction of moieties on the tube
external surface creates repulsion between the single tubes
allowing them to easily disperse into the solvent.
2.4. Noncovalent functionalization of carbon nanotubes
The noncovalent dispersion of CNT in solution allows
preservation of their aromatic structure and thus their electronic
characteristics. The dispersion procedures usually involving
ultrasonication, centrifugation and filtration are quick and easy.
Hydrophobic or k–k interactions are often evoked as likely
responsible for noncovalent stabilization. Nowadays, three
classes of molecules are mainly used for CNT dispersion.
Surfactants are used because they are easily available and low-
cost. Polymers and biopolymers (nucleic acids and peptides)
are also very efficient in the dispersion process.
2.4.1. Surfactants
A series of anionic, cationic and nonionic surfactants have
been already proposed to disperse nanotubes. Sodium dodecyl
sulfate (SDS) and Triton X-100 were used to obtain CNT
suspensions up to 0.1 and 0.5 mg/mL, respectively [27].
However, the stability of this suspension was no longer than 1
week. A better result was obtained by using sodium dodecyl-
benzene sulfonate (SDBS), which was able to provide stability
over one month reaching 10 mg/mL concentration of the
suspension. The combination of k–k interactions of aromatic
moieties between CNT and SDBS and the long lipid chains of
the SDBS increases the stability of the complex. Atomic force
microscopy (AFM) and electronic transmission microscopy
(TEM) studies of SDS/CNT dispersions showed that CNT are
mainly present as individual tubes uniformly covered by the
surfactant [28]. The types of amphiphilic molecules with long
lipid chains are able to form a half-cylinder perpendicular or
tilted around the tubes in a micelle-like arrangement [6].
Triton-X instead mainly interacts by k-stacking. Another
approach for the adsorption/dispersion of CNT via k interac-
tion resides on the use of 1-pyrenebutanoic acid activated as
succinimidyl ester, which promptly reacts with the amino
groups present in the proteins like ferritin or streptavidin [39].
The solubility of CNT was between 0.1 and 0.7 mg/mL, which
is rather low but acceptable for biological use. Although
surfactants may be efficient in the solubilization of CNT, they
are known to permeabilize plasma membranes and have a
toxicity profile of their own. Therefore, the implications
stemming from use of surfactants interacting with biological
systems can limit the possible biomedical applications of such
surfactant-stabilized CNT complexes.
2.4.2. Polymers
Polymers are widely used for example as molecular carriers
for drug delivery [40]. In the solubilization of CNT they
represent a good alternative to surfactants although they do not
have a better dispersion efficiency [28]. The mechanism of
dispersion is based in this case on wrapping of the polymeraround the tubes. Star et al. [41] have used for example a
substituted poly(metaphenylenevinylene) to suspend SWNT in
organic solvents. The polymer wraps around ropes of
nanotubes. The driving force of the phenomenon is likely to
be the steric repulsion of the polymer. Once the polymer is
attached to the surface of the nanotube, it offers a sufficient
repulsive potential stabilizing the dispersion [30]. In the case of
nonionic polymers, based on poly(oxyehtylene) copolymers,
the efficiency of the dispersion is instead due to their
hydrophilic counterpart. For particularly high molecular weight
polymers, the suspendability is enhanced as the steric
stabilization is increased by a wider coverage of the surface
[28]. In a similar approach, CNT were dispersed by using
cationic copolymers [31]. The nanotubes were covered by the
hydrophobic backbone of the polymer while the positive
tetraalkylammonium groups were exposed at the surface to
display water solubility. These types of fluorescent polymers
have also been employed to study the interaction with
mammalian cells. Poly(vinylpyrrolidone) was conjugated with
various fluorescent dyes. CNT were suspended in 1% SDS and
mixed with the fluorescent polymers to form supramolecular
complexes, which were found to have potential applications as
new molecular probes [42].
2.4.3. Biopolymers
The solubilization of CNT with biological components is
certainly more appropriate towards integration of this new type
of material with living systems. Self-assembly processes
similar to k–k interactions typical of double-stranded DNA
can be for example exploited to disperse the nanotubes.
Nucleic acids are certainly ideal candidates to form supramo-
lecular complexes based on k-stacking between the aromatic
bases and the CNT surface. Indeed, Zeng et al. [33,43] have
described an easy way to solubilize carbon nanotubes by
simple sonication in the presence of a single-strand DNA. A
molecular modeling study was performed to explain the
formation of the hybrids exerted by DNA wrapping and
subsequent CNT debundling. The DNA–nanotube complexes
displayed solubility in the range of mg/ml, and their good
stability permitted the purification using ion-exchange chro-
matography. Amphiphilic peptides belong to another class of
biopolymers that efficiently disperse CNT [44]. The presence
of amino acids like tryptophan, phenylalanine, tyrosine and
histidine into the peptide sequence plays a key role on the
solubilization process in water. These peptides could be
selected from phage-display peptide libraries [8] or by design
[44–46]. The design of highly specific peptides able to wrap
around the nanotubes represent an interesting way to assure
solubility and may even provide a useful tool for size-
separation. More recently, cyclic peptides were also proven
to have similar capabilities [47].
2.5. Covalent functionalization of carbon nanotubes
The alternative way to render CNT soluble into a wide range
of solvents is the modification of their sidewalls and tips by
organic functionalization [34–36,48]. The aqueous solubility
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hydrophilic moieties. Two main strategies are currently used to
attach functional groups to CNT (Fig. 2). The first one consists
in the oxidative treatment using strong acid solutions. The
variation of the type of acid, its concentration and the reaction
conditions (temperature, sonication) generated cut tubes
covered by carboxylic functions at their tips and at the defect
points [49]. The carboxylates were then used to incorporate a
variety of other groups to improve CNT solubility. The
introduction occurred via COOH activation using thionyl
chloride or carbodiimide. Similarly, oxidized CNT were
solubilized by direct heating in the presence of amino polymers
[50,51]. The second type of covalent functionalization is based
on the addition reactions to CNT. By exploiting the chemistry
of fullerenes, 1,3-dipolar cycloaddition of azomethine ylides,
aryl diazonium salt addition or reductive alkylation using
lithium and alkyl halides have been successfully employed to
CNT [22,34,38,52,53]. Such direct sidewall modification of
CNT permitted the incorporation of different functional groups
on the nanotube which could be further derivatized [54]. The
covalent bond presents the advantage of being more robust
during manipulation and processing in comparison to the
noncovalent dispersion. Nevertheless, both covalent and
noncovalent functionalization of CNT have been exploited
for the application of such materials in the field of drug
delivery.
3. Drug delivery by carbon nanotubes
Drug delivery systems are continuously being developed to
improve the pharmacological profile and the therapeutic
properties of administered drugs [55]. A wide variety of
delivery systems are currently available [56]. The application
of f-CNT as new nanovectors for drug delivery was apparentFig. 2. Organic functionalization of carbon nanotubes. (A) Pristine CNT can be treate
(B) CNT undergo the 1,3 dipolar cycloaddition by reacting an a-amino acid deriva
surface. R_CH3O(CH2CH2O)2CH2CH2.immediately after the first demonstration of the capacity of this
material to penetrate into cells. We demonstrated that fluores-
cently labeled CNT were uptaken by various cell types (Fig. 3,
CNT 1). CNT were functionalized using the 1,3-dipolar
cycloaddition reaction and further modified with fluorescein
isothiocyanate or a fluorescent peptide [57]. These conjugates
were tracked into the cytoplasm and the nucleus of 3T3 or 3T6
fibroblasts, respectively (Fig. 4). In a similar work, Dai and
Wender functionalized oxidized carbon nanotubes with biotin
and formed a complex with a fluorescent streptavidin. CNT
covered by the protein were found in the endosomes of CHO
and 3T3 cells [58]. The mechanism of penetration is not yet
completely elucidated. Two routes of internalization have been
proposed. It has been found that f-CNT penetrate following a
passive diffusion across the lipid bilayer similar to a
‘‘nanoneedle’’ able to perforate the cell membrane without
causing cell death [59,60]. Alternatively, when CNT were used
to deliver proteins by adsorbing them onto their external
surface, they seem to be uptaken by endocytosis [58,61].
It is highly probable that the type of molecules covalently or
noncovalently attached to the external walls of the tubes play a
critical role in the process of transport into the cells. This
capacity of CNT to cross the cell membrane was recently
exploited to deliver small organic molecules. We have shown
that CNT functionalized with amphotericin B (AmB) (Fig. 3,
CNT 2), one of the most effective antibiotic molecules for the
treatment of chronic fungal infections, are rapidly internalized
by mammalian cells with a reduced toxicity in comparison to
the drug administered alone [62]. At the highest doses, more
than 40% of cells died by effect of free AmB whereas all
mammalian cells remained alive upon treatment with AmB
covalently linked to CNT. Interestingly, the evaluation of the
antifungal activity against different types of microorganisms
showed that the effect of the AmB is enhanced whend with acid to cut them and form carboxylic groups at the tips and the sidewalls.
tive with paraformalaldehyde to add solubilizing moieties around the external
Fig. 3. Molecular structures of f-CNT capable to penetrate into the cells and display a biological function.
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and coworkers prepared a SWNT substituted with a carborane
cage for neutron boron capture therapy. After the administra-
tion of the conjugates the concentration of the boron atoms was
mostly detected in tumor cells rather than in blood or other
organs, however the mechanism for this is not yet understood
[63]. Very recently, the property of CNT to adsorb near-infrared
irradiation was exploited to kill cancer cells. Pristine SWNT
were wrapped with a poly(ethylene glycol) (PEG) modified
with a phospholipid (PL) moiety and folic acid (FA). Because
tumor cells are known to overexpress folate receptors, the PL-
PEG-FA/SWNT construct was only internalized inside cancer
cells, which were then destroyed by using a laser wavelength ofFig. 4. Confocal microscopy images of 3T6 cells incubated with fluorescent
CNT 1.808 nm. Laser pulses induced local heating and consequently
death only of those tumor cells that had uptaken the CNT [64].
f-CNT were also successfully used to deliver and present
antigenic peptide to the immune system. We prepared a
peptide-CNT conjugate containing a B cell epitope from VP1
protein of foot-and-mouth disease virus (FMDV) (Fig. 3, CNT
3). The peptide attached to SWNT could be recognized by
specific polyclonal and monoclonal antipeptide antibodies as
assessed by ELISA test and surface plasmon resonance (SPR).
This result suggested that the peptide covalently linked to CNTFig. 5. Antifungal activity of AmB conjugated to carbon nanotubes (CNT 2)
The MIC corresponds to the lowest concentration of compound that inhibits
visible growth on the pathogens. Candida parapsilosis (black bar); Candida
Albicans (dashed bar); Cryptococcus neoformans (grey bar)..
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were efficient supports for the multipresentation of peptides to
the immune system [65]. In addition, mice were immunized
with the peptide-functionalized CNT eliciting high antibody
responses with virus neutralizing capacity [66]. Importantly,
CNT devoid of the peptide moiety were not immunogenic,
since antibodies against CNT were not detected. These results
point out the potential of CNT to deliver peptide-based
synthetic vaccines.
4. Delivery of nucleic acids by carbon nanotubes
The use of f-CNT as a new carrier system for nucleic acids
is another area of research currently under investigation. The
most commonly used DNA carriers are based on viral vectors
(retrovirus, lentivirus or adenovirus), liposomes, cationic lipids,
polymers and nanoparticles [67]. Although viral vectors are
very efficient in gene expression, their use is limited because of
the concerns about their safety. Indeed, they can provoke
severe, undesired immune responses. Nonviral vectors offer
various alternatives regarding the size and type of vectors, they
are chemically controllable, and display a reduced immunoge-
nicity. However, they often present low gene expression
efficiency rates because of their poor capability in reaching
and crossing the nuclear membrane. Generally, the develop-
ment of a new vector for therapeutic gene transfer requires
protection of DNA from degradation, good membrane pene-
tration and low immunogenicity. In this context, CNT seem to
be very promising because they do not inherently trigger an
immune response [66]. Ammonium-functionalized CNT were
used to condense plasmid DNA expressing h-galactosidase
(pBgal) (Fig. 3, CNT 4) [59,68]. The complexes based on
positive/negative charge interactions were characterized using
different techniques including TEM, SPR, scanning electron
microscopy (SEM), gel electrophoresis and picogreen dye
exchange. The capacity of these complexes to induce gene
transfer was measured on CHO cells. Levels of gene
expression 5 to 10 times higher than using the plasmid DNA
alone were detected. The efficiency of f-CNT on DNA
transfection was very recently improved by conjugating
poly(ethyleneimine) (PEI) onto the external surface of the
nanotubes [69]. PEI was grafted to CNT and the conjugates
were condensed with a plasmid expressing the luciferase
marker gene. The levels of gene expression were comparable
to that of PEI alone.
Recently, Cai et al. have designed an alternative physical
method of gene transfer, appropriate only for in vitro and ex
vivo applications, called the nanotube ‘‘spearing’’ method
capable of inducing cell internalization of plasmid DNA [60].
Nanotubes grown from plasma-enhanced chemical vapor
deposition contained nickel particle catalysts entrapped into
their tips, allowing them to respond to a magnetic field. The
tubes were functionalized with a DNA strain containing the
sequence coding for the enhanced green fluorescent protein.
Dividing and non dividing cells like Bal17, B-lymphoma, ex
vivo B and primary neurons were grown on a substrate and
incubated with magnetic pDNA/CNT. A rotating magneticfield first drove the nanotubes to mechanically spear the cells.
In a subsequent step, a static magnetic field pulled the tubes
into the cells. The cells were efficiently transfected as
confirmed by fluorescent microscopy measurements. The
efficiency was equal to a viral approach even for nondividing
cells, such as primary B cells and neurons which are generally
more difficult to transfect.
The use of ammonium functionalized CNT was not limited
to complex pDNA. In fact, short oligodeoxynulceotide (ODN)
sequences were able to interact with positive charged CNT and
form stable complexes. In particular, ODN CPG motifs have
been condensed to this type of nanotubes and the immunos-
timulation properties of these complexes were evaluated [70].
High ratios of f-CNT over a minimum immunostimulatory dose
of a specific ODN CpG increased its immunopotentiating
activity in vitro and it decreased the secretion of proinflamma-
tory cytokine interleukine-6. Lu et al. have studied the
translocation of the non encoding RNA polymer poly(rU)
across MCF7 breast cancer cells using oxidized carbon
nanotubes [71]. The complex was labeled with tritiated
thymidine and was detected inside the cytoplasm as well as
in the nucleus.
In a different approach, SWNT were interacted with a
single-stranded (ss) DNA sequence labeled with the Cy3 dye
[64]. The ssDNA was transported into HeLa cells by the
nanotubes via endocytosis. Once entrapped into the endosomes
the DNA/SWNT complex was liberated by applying a near-
infrared radiation for a short time. Following the release from
the tubes into the cytoplasm, the ssDNA can freely diffuse
towards the nuclear membrane and eventually express the
encoded protein. Similarly, short interference RNA (siRNA)
for gene silencing were adsorbed onto CNT after being
covalently linked to a PEG using a cleavable disulfide bond
[72]. The siRNA/CNT complexes penetrated into the cell and
the enzymatic and acid conditions of the endosomal/lysosomal
compartments allowed the release of siRNA into the cytosol.
After crossing the nuclear membrane, siRNA carried by SWNT
achieved efficient gene silencing in comparison to the
commercially available transfection agent lipofectamine.
Overall, the results described above highlight the capacity of
f-CNT to form stable complexes with different types of nucleic
acids and their potential use in gene therapy and genetic
vaccination.
5. Toxicity
As graphite has been associated with increased dermatitis
and keratosis, investigation is needed to determine the potential
danger of exposure to CNT. Studies so far have focused on the
effects of pristine CNT on different cell lines like human
epidermal keratinocytes, HEK293 human embryonic kidney
cells, human acute monocytic leukemia cell lines, human T
cells and alveolar macrophages [73–79]. When SWNT
exposure was studied on keratinocytes, oxidative stress and
cellular toxicity were detected from the presence of free
radicals and peroxides, leading to antioxidant depletion and
loss of cell viability [79]. Inflammatory responses were also
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is likely to be due to the production of reactive oxygen species,
leading to the activation of the nuclear transcription factor-nB
[77]. Moreover, CNT can activate the human serum comple-
ment system via the classical and the alternative pathway,
generating proinflammatory peptides [80]. Studies on the
biocompatibility of SWNT on HEK293 human embryonic
kidney cells showed a cell growth inhibition via induction of
apoptosis and decrease of cell adhesion ability [73]. Pristine
nanotubes usually contain transition metal catalysts like iron or
nickel, which could explain the generation of free radicals,
however, in the case of the MWNT no iron was detected before
cellular interaction.
A comparative study on the toxicity of pristine and oxidized
MWNT onto human Jurkat T leukemia cells has shown that the
latter were more toxic [74]. CNT tend to aggregate in ropes,
decreasing in aqueous solubility and increasing in cytotoxicity.
The type of nanotubes used in such studies is therefore
extremely important. Comparison of cytotoxicity induced by
different carbon materials in alveolar macrophages showed that
SWNT provoke the highest toxic effect, followed by MWNT,
quartz and fullerenes [76]. A study on the effect of the CNT
length on cytotoxicity showed that the inflammatory response
was higher for the CNT of 825 nm in comparison to that of 220
nm [75]. CNT may lead to toxicological side-effects in the case
of biological and biomedical applications, however up to this
date this seems mainly the case for non-fuctionalized, insoluble
material. It has been previously shown that cytotoxicity of
water-soluble fullerene derivatives is improved as the degree of
surface modification is increased [81]. Thus, it is reasonable to
anticipate that functionalized and water-soluble nanotubes will
be less cytotoxic. Different types of functionalized, soluble
CNT have already been studied in various laboratories
reporting no significant cell damage by using SWNT-RNA
polymer hybrids with a concentration up to 1 mg/mL with
MCF7 breast cancer cells [71]; 90% of fibroblast survival
following incubation with 5 AM fluorescein functionalized
SWNT [57]; and no toxicity for CHO and 3T3 cells interacting
with protein-functionalized SWNT [58].
Another important aspect that plays a critical role in
determining CNT toxicity is related to their bioavailability
and deposition in lungs following inhalation. Lam et al.
described a dose-dependent formation of epitheloid granulo-
mas and some interstitial inflammations [82]. This study
showed that nanotubes were much more toxic than carbon
black and quartz. Warheit and co-workers have determined that
SWNT exposure in rats produced dose-independent series of
multifocal granulomas [83]. Recently, 125I-labelled SWNT
were radiotraced in mice following intraperitoneal administra-
tion [84]. The SWNT used in this study were water-soluble and
compatible with physiological fluid. They were shown to be
distributed among different tissues. Their excretion was mainly
through urine, and bone accumulation was reported after 18
days without any concomitant toxicity.
In summary, pristine CNT have been found to be cytotoxic
to various mammalian cell lines in vitro and to the skin and
lungs in vivo. However, pristine nanotubes tend to aggregatedue to their insolubility, therefore such toxicological responses
are not surprising. Significant efforts have been made to
improve the nanotube solubility and a remarkable reduction on
toxicity has been reported using such functionalized CNT. The
toxicological profile of CNT will depend on many parameters
such as the type of nanotubes, the presence of impurities, the
length of the tubes, the type of functionalization and the
molecular nature of the conjugated groups. It is still early to
establish a general toxicological profile for this type of material
and more systematic in vitro and in vivo investigations using
biologically compatible CNT are necessary to achieve that.
6. Conclusions
Great efforts in the development of carbon nanotubes as
advanced nanomaterials have only very recently begun to
translate into potentially useful tools for biomedical applica-
tions. Proof-of-principle studies in our laboratories and those of
others have clearly shown that carbon nanotubes, following
appropriate surface modification to render them water soluble
(i.e. biologically compatible), hold great promise as nanovec-
tors for the delivery of a variety of therapeutic and diagnostic
agents. The mechanisms of CNT interaction with mammalian
cells and their compartments is crucial in further developing
and optimizing the capabilities of carbon nanotube carrier
systems, particularly if future clinical utilization is envisaged.
Equally so, the interaction of CNT nanovectors with physio-
logical components, including blood, tissues, interstitial fluid,
the complement system, reticoloendothelial system etc., and
the ensuing toxicological profiles obtained, will determine the
clinical fate of these developing nanomedicinal tools. Never-
theless, carbon nanotubes today represent a class of emerging
nanovectors that are capable to intracellularly deliver biolog-
ically functional peptides, proteins, nucleic acids and small
molecules covalently or noncovalently attached on their
surface. Future studies will determine the opportunities as well
as the limitations that these novel nanovectors hold towards
their clinical realization.
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